Redding eye doctors explain corneal endothelial transplants
Redding ophthalmologists Dr. Michael Sumsion and Dr. Sean Sumsion outline corneal endothelial transplantation, including DMEK and DSAEK, and describe how the procedures can restore vision for patients with damaged corneal lining. The release says the targeted surgeries are used for conditions such as Fuchs’ dystrophy and corneal swelling after cataract surgery.
Why it matters: - Corneal endothelial transplantation treats damage to the innermost corneal layer, where fluid buildup can cause swelling, discomfort and blurred vision. - The procedures replace only the affected layer, which can preserve more of the patient’s natural cornea than full-thickness transplant surgery. - The approach is used to improve visual function and reduce discomfort for patients with corneal disease.
What happened: - Dr. Michael Sumsion and Dr. Sean Sumsion described corneal endothelial transplantation in a release from Riverside EyeCare Professionals in Redding, California. - The release highlights two common procedures: Descemet’s Membrane Endothelial Keratoplasty, or DMEK, and Descemet’s Stripping Automated Endothelial Keratoplasty, or DSAEK. - The doctors said the procedures can be performed on an outpatient basis using local anesthesia.
The details: - DMEK uses a very thin donor graft made mainly of endothelial cells and membrane. - DSAEK uses a slightly thicker graft that includes a small amount of supporting tissue. - Dr. Michael Sumsion said the choice between DMEK and DSAEK can depend on the patient’s condition and overall eye health. - Dr. Sean Sumsion said recovery timelines vary, but many patients can return to normal daily activities within a relatively short period. - Dr. Sean Sumsion said vision usually improves gradually as the eye heals. - Post-operative care typically includes prescribed eye drops and follow-up visits to monitor healing and watch for early complications. - The procedures are commonly used for Fuchs’ corneal dystrophy, corneal swelling after cataract surgery and some cases of graft failure after a prior transplant.
Between the lines: - The release positions endothelial transplantation as part of a broader shift toward more targeted eye surgery. - Preserving healthy corneal tissue can support a more predictable recovery in appropriate candidates. - The emphasis on outpatient treatment and shorter recovery suggests a lower-burden option than older transplant methods, though outcomes still depend on patient-specific factors.
What's next: - Dr. Michael Sumsion and Dr. Sean Sumsion say patients with corneal questions or transplant concerns should consult a qualified eye care professional. - The doctors are available for interview upon request. - More information about Dr. Michael Sumsion, Dr. Sean Sumsion and Riverside EyeCare Professionals is available here.
The bottom line: - Corneal endothelial transplantation offers a tissue-sparing option for treating certain corneal disorders, with DMEK and DSAEK providing two widely used surgical approaches.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Health Professional Times
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.